U.S. Industrial REITs Stock News

Capital raising moves put GH Research in focus GH Research (GHRS) has filed a universal shelf registration of up to US$400 million across multiple securities, alongside a US$200 million at-the-market follow-on equity program for its ordinary shares. See our latest analysis for GH Research. The capital raising plans come after a strong run, with the share price at US$21.88 and a 30 day share price return of 33.9%. The 1 year total shareholder return of 119.24% and 3 year total shareholder...

MaxCyte (NasdaqGS:MXCT) opened Q1 2026 with revenue of US$9.7 million and a basic EPS loss of US$0.04, while trailing 12 month figures show revenue of US$32.3 million and a basic EPS loss of US$0.37. The company has seen quarterly revenue move from US$10.4 million in Q1 2025 to US$9.7 million in Q1 2026, with net income moving from a loss of US$10.3 million to a loss of US$4.8 million over the same period. These figures frame the discussion for investors who are focused on how margins develop...

Costamare Bulkers Holdings (NYSE:CMDB) has opened 2026 with Q1 revenue of US$111.5 million, basic EPS of US$0.41 and net income of US$9.9 million, setting a clearer profit picture against a share price of US$19.02. The company has previously reported quarterly revenue figures ranging from US$222.9 million to US$318.9 million and a mix of positive and loss making EPS and net income results, so this quarter slots into a track record that already includes periods of pressure on earnings quality...

AI spending is no longer just a race to build the biggest models; it is increasingly about which companies can turn that investment into real earnings. With inflation pressures touching everything from fuel to freight, and central banks keeping rates higher for longer, cash generation and pricing power matter more than ever. The Profitable AI Stocks screener focuses on businesses already using AI to support profits rather than just promises. This article highlights 3 stocks from that list...

If you are wondering whether CF Industries Holdings at US$122.97 is still offering value after its run, the next sections walk through what the current price may be baking in. The stock has returned 3.6% over the last 7 days, 3.4% over the past month, 53.5% year to date and 45.1% over the last year, so recent performance is front of mind for many investors assessing what comes next. Recent news coverage has focused on CF Industries Holdings as a key player in the fertilizers and chemicals...

CareTrust REIT (CTRE) raised its 2026 earnings guidance and shared first quarter results that showed higher revenue and net income, giving investors fresh data on how the healthcare focused landlord is currently performing. See our latest analysis for CareTrust REIT. The stock has gained 15.48% year to date on a share price basis to $41.93, while the 1 year total shareholder return of 52.47% and 3 year total shareholder return above 7x suggest momentum has been strong over multiple...

If you are wondering whether Consolidated Edison at around US$107 per share still offers fair value, you will want to see how different valuation methods line up on this stock. The share price has moved 0.7% over the last week, is down 4.1% over the last month, yet shows returns of 7.1% year to date, 8.5% over 1 year, 24.5% over 3 years and 62.7% over 5 years. This gives useful context before comparing price to fundamentals. Recent headlines have focused on Consolidated Edison in relation to...

Planet Labs PBC (NYSE:PL), through its German subsidiary, has secured a significant two-year contract with the Czech Republic's State Agricultural Intervention Fund. The agreement covers satellite imagery and AI-powered analytics to support agricultural monitoring and payments across the country. The contract is a multi-year, seven-figure national government deal that expands Planet Labs' role with European public sector agencies. Planet Labs PBC operates a fleet of Earth observation...

In May 2026, Principal Financial Group announced a new API integration with benefits administration platform Employee Navigator, allowing employees to complete evidence of insurability health questions directly within their initial benefits enrollment to streamline data sharing and speed up underwriting decisions for group benefits. This move highlights Principal’s push to simplify benefits administration for more than 90,000 small and midsize employer clients by reducing enrollment...

Earlier this week, Johnson & Johnson’s Shockwave Medical unit launched the Shockwave C2 Aero coronary intravascular lithotripsy catheter globally, offering improved deliverability, lesion crossing and repositioning for treating calcified coronary artery disease in the U.S. and Japan, with Europe and Canada to follow. This next-generation device broadens Johnson & Johnson’s intravascular lithotripsy portfolio in a complex, high-need area of cardiovascular care, reinforcing the company’s...

Nurix Therapeutics announced that CEO Arthur T. Sands will join fireside chats at major upcoming healthcare conferences and that updated efficacy and safety data for its oral BTK degrader bexobrutideg (NX-5948) in chronic lymphocytic leukemia will be presented in an oral session at the 2026 European Hematology Association Congress. The oral presentation slot and conference participation highlight growing scientific and investor attention on Nurix’s targeted protein degradation pipeline,...

Camtek (NasdaqGM:CAMT) sets the tone with Q1 2026 earnings Camtek (NasdaqGM:CAMT) opened 2026 with Q1 revenue of US$121.7 million and basic EPS of US$0.68, setting a clear marker for how the year is starting to shape up. The company has seen revenue move from US$117.3 million in Q4 2024 to US$128.1 million in Q4 2025, with basic EPS across those periods ranging from US$0.73 to US$0.78, while trailing 12 month EPS sits at US$1.05 on revenue of US$499.1 million. With a trailing net margin of...

Rising inflation worries, higher bond yields and choppy energy markets are putting pressure on weaker companies, especially those that rely heavily on cheap financing to survive. That environment can be harsh for most penny stocks, which often run out of cash before their plans get off the ground. The Elite Penny Stocks screener focuses only on companies with balance sheets that look better equipped to fund their ambitions. In this article, you will see 3 of the most interesting stocks from...

Why Trinity Capital's fresh equity raise matters after earnings Trinity Capital (TRIN) has followed its recent first quarter earnings release with a new at the market follow on equity offering of up to US$300 million in common stock. The timing links two key themes investors tend to focus on: quarterly profitability and balance sheet capacity. It also raises fresh questions about how the company might deploy additional capital against its existing tech lending and equipment financing...

Rising interest in Oklo (OKLO) is being driven by a cluster of fresh updates, including wider first quarter losses, a sizeable cash position, accelerated U.S. regulatory progress, and a new AI focused partnership with Idaho National Laboratory. See our latest analysis for Oklo. Oklo’s share price has pulled back in the very short term, with a 1 day share price return down 3.52% and a 7 day share price return down 6.43%, even after a 14.73% 30 day share price return and a very large 3 year...

Paysign, Inc. reported past first-quarter 2026 results on May 12, posting revenue of US$28.04 million and net income of US$5.44 million, with diluted EPS of US$0.09 from continuing operations. The quarter marked a shift as patient affordability programs became Paysign’s largest revenue contributor, reflecting a mix change toward higher-margin pharma offerings. We’ll now examine how this record first quarter and the rise of patient affordability as Paysign’s largest revenue stream affect its...

Wondering if Kimberly-Clark at around US$96.67 is offering value or just reflecting its challenges? This breakdown aims to help you frame that question clearly before you commit fresh capital. The stock is down 2.9% over the past week, 0.5% over the past month and 4.7% year to date, with a decline of 26.5% over one year, 24.5% over three years and 12.2% over five years, which may have some investors reassessing both risk and potential upside. Recent coverage around Kimberly-Clark has focused...

In the past quarter, CNX Resources Corporation reported first-quarter 2026 revenue of US$786.65 million versus US$82.39 million a year earlier, with net income of US$348.15 million replacing a net loss of US$197.72 million. This sharp swing back to profitability, alongside strong operational metrics and broad shareholder support for the current board and executive pay, highlights how tightly aligned governance, efficiency, and earnings power have become for the Appalachian gas...

Dutch Bros (BROS) is back in focus after reporting higher than expected Q1 2026 revenue, raising full year guidance, and pushing ahead with an aggressive store rollout that includes new shops in the Chicago suburbs and Greenville. See our latest analysis for Dutch Bros. Despite upbeat Q1 results and a steady drumbeat of new shop openings and product launches, Dutch Bros’ momentum has cooled. The 1-day share price return of 3.31% contrasts with a year-to-date share price decline of 19.56% and...

Charles Schwab (NYSE:SCHW) has begun a phased rollout of direct Bitcoin and Ether trading for eligible retail clients. The new Schwab Crypto platform offers spot crypto trading alongside existing ETF-based exposure. This is the first time Schwab has integrated spot crypto trading into its core brokerage ecosystem. For investors watching NYSE:SCHW, this move comes with the stock at $89.44 and a mixed performance profile. Shares are down 9.1% over the past 30 days and down 11.9% year to date,...

First quarter earnings signal ongoing pressures Service Properties Trust (SVC) reported first quarter 2026 earnings with revenue of US$364.45 million and a net loss of US$151.18 million, extending losses compared with the same period last year. Sales from certain operations were US$99.88 million, slightly below the prior year. Basic loss per share from continuing operations widened to US$0.91. For investors, the update highlights continuing operational and profitability pressures. See our...

Affirm Holdings (NasdaqGS:AFRM) is expanding its partnership with Google to embed buy now, pay later options into Google Search results and the Gemini app via Google Pay. The new integration brings Affirm's pay over time product directly into shopping journeys for hundreds of millions of Google users. This development broadens Affirm's reach with consumers and merchants inside a core part of the global digital shopping and search experience. Affirm operates a buy now, pay later platform...

Q1 earnings and guidance put Solstice Advanced Materials (SOLS) in focus Solstice Advanced Materials (SOLS) has come into focus after reporting first quarter 2026 earnings showing revenue of US$991 million and net income of US$85 million, alongside fresh second quarter and full year net sales guidance. See our latest analysis for Solstice Advanced Materials. At a share price of US$86.81, Solstice Advanced Materials has seen a 7 day share price return of 11.64% and a year to date share price...

BETA Technologies (NYSE:BETA) was selected for seven of eight FAA eVTOL Integration Pilot Programs in the past week. The company received a commercial aircraft order from Surf Air Mobility, expanding its confirmed backlog. BETA launched cargo and medical operations and advanced partnerships with GE Aerospace and General Dynamics. The company continued to roll out its nationwide charging network to support electric aviation operations. At a share price of $16.61, NYSE:BETA has had a tough...